Valuation: DexCom, Inc.

Market Cap 26.57B 23.22B 21.32B 19.88B 37.69B 2,530B 38.33B 257B 99.49B 1,241B 99.77B 97.6B 4,275B P/E 2026 *
28.1x
P/E 2027 * 23.6x
Enterprise Value 26.17B 22.86B 21B 19.58B 37.12B 2,491B 37.74B 253B 97.97B 1,222B 98.25B 96.11B 4,210B EV / Sales 2026 *
5.01x
EV / Sales 2027 * 4.35x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day+3.36%
1 week+3.80%
Current month+5.81%
1 month-2.98%
3 months+14.53%
6 months+7.09%
Current year+7.37%
1 week 67.3
Extreme 67.3
71.35
1 month 67.3
Extreme 67.3
78.91
Current year 56.72
Extreme 56.72
78.91
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Date Insider Type Main position Quantity % Market Cap.
06-14Sell

General Counsel

-1,700 0.0004%
06-14Sell

Director

-4,000 0.0010%
06-03Sell

Executive/Senior Manager

-4,911 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+3.31%+3.80%-14.74%-43.90% 26.57B
+3.55%+2.40%-28.80%-10.95% 161B
+4.15%+2.53%-6.48%-5.26% 101B
+1.41%+1.81%+0.33%+53.02% 56.12B
-1.22%-2.88%+53.69%+49.87% 53.35B
+2.59%+3.53%-11.59%-40.16% 42.13B
+2.16%+13.13% - - 35.29B
+0.17%+5.74%+65.65%-3.14% 25.79B
+2.40%+3.35%-8.64%-0.67% 20.69B
+2.69%+1.40%-14.89%-2.92% 19.59B
Average +2.18%+2.67%+3.84%-0.46% 54.15B
Weighted average by Cap. +2.63%+1.89%-4.06%+0.66%

Financials

2026 *2027 *
Net sales 5.22B 4.57B 4.19B 3.91B 7.41B 497B 7.54B 50.48B 19.56B 244B 19.62B 19.19B 841B 5.83B 5.09B 4.68B 4.36B 8.27B 555B 8.41B 56.32B 21.83B 272B 21.89B 21.41B 938B
Net income 963M 841M 772M 720M 1.37B 91.64B 1.39B 9.3B 3.6B 44.95B 3.61B 3.54B 155B 1.16B 1.01B 929M 866M 1.64B 110B 1.67B 11.18B 4.33B 54.06B 4.35B 4.25B 186B
Net Debt -405M -354M -325M -303M -575M -38.56B -584M -3.91B -1.52B -18.91B -1.52B -1.49B -65.17B -1.21B -1.06B -972M -906M -1.72B -115B -1.75B -11.7B -4.54B -56.56B -4.55B -4.45B -195B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-07-02 US$71.24 +3.46% 1,253,411
26-07-01 US$68.86 +2.24% 4,793,643
26-06-30 US$67.35 -3.76% 4,300,556
26-06-29 US$69.98 -0.23% 3,978,772
26-06-26 US$70.14 +2.17% 6,872,596
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
68.86USD
Average target price
85.24USD
Spread / Average Target
+23.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock